PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test
December 19, 2019 09:30 ET
|
PAVmed Inc.
First commercially available DNA test designed to facilitate the diagnosis of Barrett’s Esophagus and related precursors to highly lethal form of esophageal cancer First patients to undergo testing...
PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer
February 28, 2019 12:49 ET
|
PAVmed Inc.
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced that its...
PAVmed Provides Business Update
October 17, 2018 07:30 ET
|
PAVmed Inc.
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
Medigus’ MUSE™ Continues to Gain Clinical Adoption in the U.S.
June 24, 2016 10:18 ET
|
Medigus Ltd
OMER, Israel, June 24, 2016 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...
Innovative Med Concepts Debuts Revolutionary iPhone(R) App Designed to Monitor Daily Health Habits and Improve Well-Being
May 22, 2012 08:00 ET
|
Innovative Med Concepts, LLC
TUSCALOOSA, AL--(Marketwire - May 22, 2012) - Privately held Innovative Med Concepts, LLC today announced the availability of UShapeHealth, a new, user-friendly, mobile health application for the...